Look behind the lecture: Zhiyong Xie explores the state of AI drug safety research and development

In this interview with Zhiyong (Sean) Xie of Pfizer (NY, USA), we discuss his recent talk at the AI Drug Discovery & Development Summit (16–17 August 2022, MA, USA), where he discussed AI applications in drug safety studies in detail. We explore how Sean’s interest in AI began and his career since then, the current state of AI-assisted drug safety assessments and what the future holds for AI drug discovery. What sparked your interest in AI in medicine and how has the field progressed since? I started learning about AI when I was in the graduate school of Peking University...